Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1994 Mar;69(3):620–621. doi: 10.1038/bjc.1994.116

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.

I Cohen, D J Rosen, M Altaras, Y Beyth, J Shapira, D Yigael
PMCID: PMC1968870  PMID: 8123501

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbieri R. L., Ferracci A. L., Droesch J. N., Rochelson B. L. Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer. Fertil Steril. 1993 Feb;59(2):459–460. doi: 10.1016/s0015-0282(16)55688-x. [DOI] [PubMed] [Google Scholar]
  2. Dilts P. V., Jr, Hopkins M. P., Chang A. E., Cody R. L. Rapid growth of leiomyoma in patient receiving tamoxifen. Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):167–168. doi: 10.1016/0002-9378(92)91854-4. [DOI] [PubMed] [Google Scholar]
  3. Jolles C. J., Smotkin D., Ford K. L., Jones K. P. Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman. A case report. J Reprod Med. 1990 Mar;35(3):299–300. [PubMed] [Google Scholar]
  4. Powles T. J., Hardy J. R., Ashley S. E., Farrington G. M., Cosgrove D., Davey J. B., Dowsett M., McKinna J. A., Nash A. G., Sinnett H. D. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer. 1989 Jul;60(1):126–131. doi: 10.1038/bjc.1989.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ravdin P. M., Fritz N. F., Tormey D. C., Jordan V. C. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Res. 1988 Feb 15;48(4):1026–1029. [PubMed] [Google Scholar]
  6. Sawka C. A., Pritchard K. I., Paterson A. H., Sutherland D. J., Thomson D. B., Shelley W. E., Myers R. E., Mobbs B. G., Malkin A., Meakin J. W. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma. Cancer Res. 1986 Jun;46(6):3152–3156. [PubMed] [Google Scholar]
  7. Spicer D. V., Pike M. C., Henderson B. E. Ovarian cancer and long-term tamoxifen in premenopausal women. Lancet. 1991 Jun 8;337(8754):1414–1414. doi: 10.1016/0140-6736(91)93096-r. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES